查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197543

醫用管材市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Medical Tubing Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在研究期間（2022-2027 年），醫用管材市場預計將以 8.5% 的複合年增長率增長。

最近，各國都面臨著 COVID-19 的巨大威脅。 由於供應鏈中斷和住院人數增加，醫用管材市場增長受到 COVID-19 的嚴重影響。 2020 年 4 月發表的一篇文章“嚴重供應短缺——COVID-19 大流行期間對呼吸機和個人防護設備的需求”指出，與 COVID-19 相關的並發症迅速增加，導致死亡，導致指出對船隻的需求將會增加。 因此，對呼吸機的需求增加也導致對呼吸機管的需求激增，從而推動了市場的增長。 然而，由於 COVID-19 導致的關閉、勞動力短缺、塑料和橡膠等原材料的產量減少以及原材料價格飆升對醫用管材的生產產生了重大影響，給市場增長帶來了壓力。

所研究的市場增長驅動因素包括慢性病和人口老齡化負擔的增加、對微創醫療程序的需求增加以及對一次性管狀醫療設備的需求增加。 此外，主要市場參與者的新產品發布和戰略舉措將進一步推動市場增長。

根據 2022 年 1 月發表的文章“未來微創手術的微電子導管”，導管是一種微創手術，可輕鬆去除血塊、植入植入物或靶向輸送藥物。它具有重要意義手術的重要性，旨在對患者特別友好。 這種導管的優勢將增加它們的需求，預計在研究期間需求會增加，從而推動研究市場。

此外，產品發布、合併、收購和合作夥伴關係等戰略舉措也將帶來利潤豐厚的市場增長。 例如，2021 年 4 月，BioCardia, Inc. 與日本領先的生物技術公司之一就其 BioCardia Helix 導管生物治療遞送產品候選產品達成協議。 這是 BioCardia Helix 導管生物治療師交付的候選產品的特定細胞類型的心臟適應症的非排他性全球許可。 根據協議，BioCardia 將獲得 500,000 美元用於生物治療藥物遞送產品和支持服務。

此外，2021 年 6 月，Zeus Industrial Products 宣布收購 CathX Medical Inc.，這是一家醫療設備合同製造公司，為客戶提供導管設計工程服務、快速原型製作、製造、完整或子組裝的單一來源. 獲得了 . 此次收購擴大了 Zeus 的產品組合和地理範圍，推動了市場增長。 同樣在 2022 年 2 月，Zeus Industrial Products 在其專為可操縱導管設計的產品組合中推出了 PTFE Sub-Lite-Wall 多腔管。

因此，由於上述因素，該研究涵蓋的市場預計在研究期間將顯著增長。 然而，產品開發的巨大投資和時間預計將阻礙研究期間的市場增長。

醫用管材市場趨勢

預計在預測期內，導管和插管部分將佔據很大的市場份額

導管是一根塑料管，可插入已有開口的區域，例如膀胱或開放性傷口，用於幫助引流液體。 另一方面，插管是一根小塑料管，借助針刺穿靜脈或血管，將其插入身體的一部分。 然後取出針頭，將插管留在原位，以便於取出或向血管中註入任何東西。

外周動脈疾病、慢性腎病等慢性病負擔的增加、老年人口的增加、產品發布的增加以及所研究細分市場參與者的其他戰略舉措可能會帶來利潤豐厚的市場增長。

例如，根據 2021 年 6 月發表的研究論文《外周動脈疾病和多血管疾病的流行病學》，美國外周動脈疾病的患病率估計約為 7%，據信有 850 萬成年人影響 因此，PAD的高負擔有望增加早期治療的需求並影響醫用管材的需求。

此外，該細分市場中產品的推出預計將對市場增長做出重大貢獻。 例如，2021 年 4 月，DORC 推出了 EVA AVETA 套管針系統，該系統集成了推入配合注射連接和激光蝕刻保持功能。 這為外科醫生和患者帶來了好處，例如流量增加、工作尺寸減小和術中眼壓穩定。

此外，2021 年 7 月，美敦力公司將在獲得 CE 標誌後在歐洲推出 Prevail 藥物塗層球囊 (DCB) 導管。 Prevail DCB 在經皮冠狀動脈介入治療 (PCI) 過程中用於治療冠狀動脈疾病 (CAD) 患者狹窄或阻塞的冠狀動脈。

因此，由於上述因素，研究部門有望為市場的顯著增長做出貢獻。

北美將佔據很大的市場份額，預計在預測期內也會如此

北美醫用導管市場增長的主要驅動力是慢性病和老年人口的增加、產品發布的增加、對微創手術的需求增加以及主要市場參與者的戰略舉措不斷增加。

在研究期間，預計北美地區的美國將佔據調查市場的很大份額。 例如，根據美國 2022 年 7 月腎臟疾病統計更新，慢性腎臟疾病 (CKD) 影響美國超過七分之一的成年人，而該國患有腎臟疾病的美國人估計有 3700 萬。 國內 CKD 負擔的加重將增加對導尿管的需求並推動市場。

此外，同一市場的產品上市和獲批也將提振市場。 例如，2021 年 8 月，Argon Medical Devices, Inc. 在美國宣布推出 SKATER Mini-Loop Drainage Catheters，這是一種圖像引導並穿過皮膚放置的微創方法，用於去除或排出不需要的液體池。現在發售中。

2021 年 11 月，The Flume Catheter Company Ltd.（以下簡稱 The Flume. Ltd. (TFCC)）獲得美國食品和藥物管理局 (FDA) 的批准，可以在美國銷售 FLUME 導管。

2022 年 3 月，Shockwave Medical 推出了 Shockwave M5+ 外周 IVL 導管，並獲得美國食品藥品監督管理局 (FDA) 的批准。 Shockwave M5+ 導管專門設計用於減少血管內碎石術 (IVL) 治療時間，提供替代通路選擇，並將 IVL 治療擴展至血管尺寸較大的患者。

此外，併購和開設媒體網站等戰略舉措有助於提高現有產品的知名度和擴大市場，對市場的增長做出了重大貢獻。

因此，由於上述因素，所研究的市場有望帶來北美市場的有利可圖的增長。

醫用導管市場競爭者分析

醫用管材市場競爭激烈。 主要市場參與者採用的併購和合作夥伴關係等戰略舉措將推動市場增長。 市場上的主要參與者有 Saint-Gobain、Freudenberg Medical、W. L. Gore & Associates, Inc.、The Lubrizol Corporation、Raumedic AG 等。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 慢性病和人口老齡化負擔加重
    • 對微創醫療程序的需求不斷增長
    • 對一次性管狀醫療器械的需求增加
  • 市場製約因素
    • 產品開發需要大量投資和時間
  • 五力分析分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模 - 百萬美元）

  • 按材料
    • 塑料
    • 橡膠
    • 特種聚合物
  • 通過使用
    • 散裝一次性試管
    • 給藥系統
    • 導管/插管
    • 其他（蠕動泵管、供氣管、排煙管）
  • 按結構
    • 單腔
    • 共擠
    • 多流明
    • 編織管
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Saint-Gobain
    • Freudenberg Medical
    • W. L. Gore & Associates, Inc.
    • The Lubrizol Corporation
    • Raumedic AG
    • Nordson Corporation
    • MDC Industries
    • ZARYS International Group
    • Hitachi, Ltd.
    • NewAge Industries
    • TE Connectivity
    • Optinova

第7章 市場機會今後動向

簡介目錄
Product Code: 90513

The Medical Tubing Market is Expected to witness a CAGR of 8.5% during the study period (2022-2027).

In recent times, countries have faced a huge threat of COVID-19. The medical tubing market growth was significantly impacted by COVID-19 owing to supply chain disruptions and an increase in hospital admissions. The article "Critical Supply Shortages - The Need for Ventilators and Personal Protective Equipment during the COVID-19 Pandemic," published in April 2020, indicated that there was an increase in demand for ventilators as the complications associated with COVID-19 were surging and leading to mortality. Therefore, this increase in ventilator demand also surged the demand for ventilator tubing, which has driven the market growth. However, the production of medical tubes was severely impacted due to COVID-19-induced lockdown, labor shortage, decrease in the production of raw materials such as plastics and rubbers, the surge in prices of raw materials, and others that were a burden on the market growth.

The factors propelling the studied market growth are the growing burden of chronic diseases and the geriatric population, rising demand for minimally invasive medical procedures, and increasing demand for disposable tube-based medical devices. In addition, new product launches and strategic initiatives taken by the key market players will further drive the market growth.

As per the article "Microelectronic Catheter for Minimally Invasive Surgery of the Future," published in January 2022, catheters are significantly important for minimally invasive surgery due to easily procedures for the removal of blood clots, the insertion of implants, or the targeted administration of drugs, and are intended to be particularly gentle for patients. Such advantages of catheters increase their demand and are expected to increase during the study period, which will boost the studied market.

Additionally, strategic initiatives such as product launches, mergers, and acquisitions, partnerships, and others will also lead to lucrative growth of the market. For instance, in April 2021, BioCardia, Inc. entered into an agreement with one of the leading Japanese biotechnology companies related to BioCardia Helix catheter biotherapeutic delivery product candidates. It is a non-exclusive, worldwide license to BioCardia Helix catheter biotherapeutic delivery product candidates for certain cell types for cardiac indications. Under the terms of the agreement, BioCardia will receive USD 500,000 for biotherapeutic delivery products and support services.

Furthermore, in June 2021, Zeus Industrial Products, Inc. acquired CathX Medical Inc., a medical device contract manufacturer that offers customers a single source for catheter design engineering services, rapid prototyping, manufacturing, and full or sub-assemblies. Such acquisition will expand the product offerings of Zeus and its geographical footprints, which will drive market growth. Also, In February 2022, Zeus Industrial Products launched its PTFE Sub-Lite-Wall multi-lumen tubing to its product portfolio designed for steerable catheters.

Therefore, owing to the aforementioned factors, the studied market is expected to grow significantly during the study period. However, huge investments and time required for product development are expected to hinder the market growth during the study period.

Medical Tubing Market Trends

Catheters and Cannulas Segment is Expected to Account for the Large Market Share During the Forecast Period

A catheter is a plastic tube that is inserted into an area of the body that already has an opening, such as the bladder or an open wound that need needs assistance in draining. However, a cannula is a small plastic tubing that is inserted into part of the body with the help of a needle that punctures the vein or vessel. The needle is then removed, leaving the cannula in place for easy access to withdraw or inject anything into the vessel.

The growing burden of chronic diseases such as peripheral artery diseases, chronic kidney diseases, and others, the growing geriatric population, increase in product launches, and other strategic initiatives by players in the studied segment will lead to lucrative growth of the market.

For instance, according to the research article "Epidemiology of Peripheral Artery Disease and Polyvascular Disease," published in June 2021, the prevalence of peripheral artery disease in the United States is estimated to be approximately 7%, affecting 8.5 million adults. Thus, the high burden of PAD is expected to increase the demand for early treatment, impacting the demand for medical tubing.

Additionally, product launches in the segment will contribute significantly to the market growth. For instance, in April 2021, DORC launched the EVA AVETA trocar cannula system, which integrates a push-fit infusion connection and a laser-etched retention feature. This will benefit surgeons and patients through improved flow rates, a smaller working size, and more stable intra-operative intraocular pressure.

Furthermore, in July 2021, Medtronic plc launched Prevail drug-coated balloon (DCB) Catheter in Europe following the CE mark. The Prevail DCB is used during percutaneous coronary intervention (PCI) procedures to treat narrowed or blocked coronary arteries in patients with coronary artery disease (CAD).

Thus, due to the above-mentioned factors, the studied segment is expected to contribute to the significant growth of the market.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

The primary driving factors for the growth of the North American medical tubing market are the increasing prevalence of chronic diseases and the geriatric population, increasing product launches, increasing demand for minimally invasive procedures, and rising strategic initiatives by key market players.

The United States within North America is expected to hold a significant share of the studied market during the study period. For instance, According to the Kidney Disease Statistics updated in July 2022 for the United States, Chronic kidney disease (CKD) affects more than 1 in 7 United States adults, and it is estimated that 37 million Americans suffer from kidney disease in this country. The growing burden of CKD in the country will increase the demand for urinary catheters, thereby driving the market.

Moreover, product launches and approvals in the market will also boost the market. For instance, in August 2021, Argon Medical Devices, Inc. launched SKATER Mini-Loop Drainage Catheters in the United States, which will be placed through the skin using imaging guidance as a minimally invasive way to remove or drain an unwanted fluid collection.

In November 2021, The Flume Catheter Company Ltd. (TFCC), a medical device company dedicated to developing an improved alternative to the Foley indwelling urinary catheter, received clearance from the United States Food and Drug Administration (FDA) to market the FLUME catheter in the United States.

In March 2022, Shockwave Medical, Inc. launched Shockwave M5+ peripheral IVL catheter after receiving United States Food and Drug Administration (FDA) clearance. The Shockwave M5+ catheter is specifically designed to decrease Intravascular Lithotripsy (IVL) treatment time, provide alternative access options, and expand IVL therapy to patients with larger vessel sizes.

Additionally, strategic initiatives such as mergers and acquisitions, the establishment of media sites, and others by the key market players will help them in creating awareness about their existing products and expanding their reach, thus, contributing to the market growth significantly.

Therefore, due to the above-mentioned factors, the studied market is expected to lead to lucrative growth of the market in North America.

Medical Tubing Market Competitor Analysis

The medical tubing market is moderately competitive. The market growth is boosted by strategic initiatives such as mergers and acquisitions and partnerships adopted by the key market players. The major players in the market are Saint-Gobain, Freudenberg Medical, W. L. Gore & Associates, Inc., The Lubrizol Corporation, Raumedic AG, and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Chronic Diseases and Geriatric Population
    • 4.2.2 Rising Demand for Minimally Invasive Medical Procedures
    • 4.2.3 Increasing Demand of Disposable Tube Based Medical Devices
  • 4.3 Market Restraints
    • 4.3.1 Huge Investments and Time Required for Product Development
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Material
    • 5.1.1 Plastics
    • 5.1.2 Rubbers
    • 5.1.3 Specialty Polymers
  • 5.2 By Application
    • 5.2.1 Bulk Disposable Tubing
    • 5.2.2 Drug Delivery Systems
    • 5.2.3 Catheters and Cannulas
    • 5.2.4 Others (Peristaltic Pump Tubing, Gas Supply Tubing and Smoke Evacuation Tubing)
  • 5.3 By Structure
    • 5.3.1 Single Lumen
    • 5.3.2 Co-Extruded
    • 5.3.3 Multi Lumen
    • 5.3.4 Braided Tubing
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Saint-Gobain
    • 6.1.2 Freudenberg Medical
    • 6.1.3 W. L. Gore & Associates, Inc.
    • 6.1.4 The Lubrizol Corporation
    • 6.1.5 Raumedic AG
    • 6.1.6 Nordson Corporation
    • 6.1.7 MDC Industries
    • 6.1.8 ZARYS International Group
    • 6.1.9 Hitachi, Ltd.
    • 6.1.10 NewAge Industries
    • 6.1.11 TE Connectivity
    • 6.1.12 Optinova

7 MARKET OPPORTUNITIES AND FUTURE TRENDS